Naptumomab Estafenatox Recombinant Monoclonal Antibody for SPR, Flow, ELISA, Functional Naptumomab Estafenatox has been used in trials studying the treatment of Pancreatic Cancer, Renal Cell Carcinoma, and Non-Small-Cell Lung Carcinoma.
Naptumomab Estafenatox Recombinant Monoclonal Antibody for SPR, Flow, ELISA, Functional Naptumomab Estafenatox has been used in trials studying the treatment of Pancreatic Cancer, Renal Cell Carcinoma, and Non-Small-Cell Lung Carcinoma.
Read more ...